If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
A woman in her early 20s underwent bilateral photorefractive keratectomy (PRK) for correction of myopia. She developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results